SBHMY
Price
$20.16
Change
+$0.66 (+3.38%)
Updated
Aug 27 closing price
Capitalization
18.27B
SPHRF
Price
$0.10
Change
+$0.02 (+25.00%)
Updated
Aug 26 closing price
Capitalization
60.14M
Interact to see
Advertisement

SBHMY vs SPHRF

Header iconSBHMY vs SPHRF Comparison
Open Charts SBHMY vs SPHRFBanner chart's image
Sino Biopharmaceutical
Price$20.16
Change+$0.66 (+3.38%)
Volume$264
Capitalization18.27B
Starpharma Holdings
Price$0.10
Change+$0.02 (+25.00%)
Volume$23.82K
Capitalization60.14M
SBHMY vs SPHRF Comparison Chart in %
Loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SBHMY vs. SPHRF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Hold and SPHRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (SBHMY: $19.90 vs. SPHRF: $0.10)
Brand notoriety: SBHMY and SPHRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 43% vs. SPHRF: 132%
Market capitalization -- SBHMY: $18.27B vs. SPHRF: $60.14M
SBHMY [@Biotechnology] is valued at $18.27B. SPHRF’s [@Biotechnology] market capitalization is $60.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 2 FA rating(s) are green whileSPHRF’s FA Score has 0 green FA rating(s).

  • SBHMY’s FA Score: 2 green, 3 red.
  • SPHRF’s FA Score: 0 green, 5 red.
According to our system of comparison, SBHMY is a better buy in the long-term than SPHRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBHMY’s TA Score shows that 3 TA indicator(s) are bullish while SPHRF’s TA Score has 2 bullish TA indicator(s).

  • SBHMY’s TA Score: 3 bullish, 2 bearish.
  • SPHRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SBHMY is a better buy in the short-term than SPHRF.

Price Growth

SBHMY (@Biotechnology) experienced а 0.00% price change this week, while SPHRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($18.3B) has a higher market cap than SPHRF($60.1M). SBHMY YTD gains are higher at: 147.190 vs. SPHRF (33.970).
SBHMYSPHRFSBHMY / SPHRF
Capitalization18.3B60.1M30,449%
EBITDAN/A-13.7M-
Gain YTD147.19033.970433%
P/E Ratio33.24N/A-
RevenueN/A2.98M-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SBHMY vs SPHRF: Fundamental Ratings
SBHMY
SPHRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
3642
P/E GROWTH RATING
1..100
17100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (2) in the null industry is in the same range as SPHRF (34). This means that SBHMY’s stock grew similarly to SPHRF’s over the last 12 months.

SBHMY's Profit vs Risk Rating (100) in the null industry is in the same range as SPHRF (100). This means that SBHMY’s stock grew similarly to SPHRF’s over the last 12 months.

SBHMY's SMR Rating (96) in the null industry is in the same range as SPHRF (97). This means that SBHMY’s stock grew similarly to SPHRF’s over the last 12 months.

SBHMY's Price Growth Rating (36) in the null industry is in the same range as SPHRF (42). This means that SBHMY’s stock grew similarly to SPHRF’s over the last 12 months.

SBHMY's P/E Growth Rating (17) in the null industry is significantly better than the same rating for SPHRF (100). This means that SBHMY’s stock grew significantly faster than SPHRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBHMYSPHRF
RSI
ODDS (%)
Bearish Trend 3 days ago
27%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
39%
Bullish Trend 3 days ago
41%
Momentum
ODDS (%)
Bearish Trend 3 days ago
43%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
35%
Bullish Trend 3 days ago
41%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
40%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
29%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 3 days ago
14%
View a ticker or compare two or three
Interact to see
Advertisement
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BWXT180.624.41
+2.50%
BWX Technologies
SEED1.120.02
+2.16%
Origin Agritech Limited
AACT9.49N/A
N/A
Ares Acquisition Corp
HCM15.64-0.15
-0.95%
HUTCHMED (China) Limited
VSME2.50-0.48
-16.11%
VS Media Holdings Limited

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with CMVLF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
CMVLF - SBHMY
51%
Loosely correlated
N/A
SYBX - SBHMY
39%
Loosely correlated
+4.82%
BTAI - SBHMY
32%
Poorly correlated
-4.26%
TENX - SBHMY
27%
Poorly correlated
+6.61%
SPHRF - SBHMY
24%
Poorly correlated
N/A
More

SPHRF and

Correlation & Price change

A.I.dvisor tells us that SPHRF and SYBX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and SYBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
SYBX - SPHRF
29%
Poorly correlated
+4.82%
SPHRY - SPHRF
26%
Poorly correlated
N/A
SOLTF - SPHRF
23%
Poorly correlated
-5.19%
RNXT - SPHRF
22%
Poorly correlated
+0.85%
PYPD - SPHRF
21%
Poorly correlated
-1.04%
More